Cancer Screening
U.S. National Cancer Institute in vitro drug screening has expanded
Published in Medical Letter on the CDC and FDA, July 4th, 2004
According to recent research from the United States, "Development of new anticancer drugs is a costly and risky proposition. The Developmental Therapeutics Program (DTP) of the National Cancer Institute of the United States (U.S.) facilitates the drug development process by providing access to preclinical screening services."
"Since the early 1990s, DTP has screened tens of thousands of compounds against a panel of 60 human tumor cell lines representing 9 tissue sites. At the same time, DTP began to accumulate information on the expression of molecular entities in the same...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Letter on the CDC and FDA
More Articles from Medical Letter on the CDC and FDA
- Bartonella
Diversity of Bartonella in rodents of Thailand determined - Colon Cancer
States awarded grant for colorectal cancer prevention educational program - MMR Vaccine
Measles-mumps-rubella vaccination recommended at 12 to 15 months of age - Outbreaks
Model for disease outbreaks in realistic urban networks developed - Age-Related Macular Degeneration
SnET2 NDA accepted by FDA with priority review designation - Allergy Medicine
National study shows 82% of U.S. homes have mouse allergens - More from this issue of Medical Letter on the CDC and FDA
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
